BC-005

N/A

Report date: 2026/03/19 17:01:18

Base Information

Drug NameBC-005
Drug Alias NameBC-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Glypican-3Anti-CD3Wnt signalling pathway inhibitors
TargetsT cell surface glycoprotein CD3Glypican-3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Buchang Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Buchang Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A